Table 4.
Contribution of variables to OIT response with ΔHb increment evaluated by multiple linear regression analysis.
| Variable | Regression Coefficient | p-Value | 95% CI |
|---|---|---|---|
| Age | 0.001 | 0.920 | [−1.329, 0.462] |
| Gender | 0.001 | 0.998 | [−0.717, 0.719] |
| DM or non DM | −0.433 | 0.333 | [−1.329, 0.462] |
| Serum hepcidin-25 | −0.008 | 0.338 | [−0.026, 0.009] |
| Baseline Hb | −0.146 | 0.466 | [−0.550, 0.257] |
| MCV | −0.071 | 0.107 | [−0.159, −0.016] |
| Serum ferritin | −0.004 | 0.786 | [−0.037, 0.028] |
| Serum iron | 0.004 | 0.546 | [0.010, 0.018] |
| Serum transferrin | 0.007 | 0.671 | [−0.027, 0.041] |
| CRP | 1.095 | 0.289 | [−0.967, 0.157] |
| CERA dose | 0.343 | 0.487 | [−0.647, 1.334] |
CERA, continuous erythropoietin receptor activator (methoxy polyethylene glycol-epoetin-β); CI, confidence interval; CRP, C-reactive protein; DM, diabetes mellitus; Hb, hemoglobin; ΔHb, change in Hb after OIT from baseline; MCV, mean corpuscular volume.